With CAR-T therapies on the cusp of achieving global approval, there are still many bottlenecks that are preventing this from becoming the ‘sell-out’ therapy that the field had hoped for. […]

Translating Emerging Antigen Specific Immune Tolerance Approaches for Therapeutic Applications Accelerate the progression of ethical and effective antigen specific immunotherapies through the clinic, optimize the discovery of novel targets and […]

After three decades of trial and error to target the driver of 30% of all diagnosed cancers, scientists are finally making meaningful clinical progression to target the cancer master switch, […]

Returning to Boston in February 2020 is the 8th Neurodegenerative Drug Development Summit, previously World CNS. Despite the lack of clinical trial success, new investments are being made in forward-thinking […]